Volume of wastewater sludge treated, reused or recycled
Unit
: Metric tonnes (t)
Indicator
: Wastewater discharged
Metric Type
: Response
Frameworks alignment notes
E3-4 28 (c)
9.2.9
Water pollution - Nutrient loading via wastewater
Refer to AMR's Common Antibiotic Manufacturing Framework for alignment to metric
- Refer to the PSCI's Decarbonization Playbook for the Pharmaceutical Industry for alignment to the metric
- Refer to PSCI's Environmental Survey For Suppliers
WHO guidance
T7, T11, T16
Target example
[Company name] will increase the proportion of [wastewater sludge] that is [treated, reused, recycled] in [business activity or facility] by [target amount, in absolute tonnes, or percentage] by [target year], compared to a [baseline year] baseline.
Target Source: WBCSD target template
Sector
Pharmaceutical
Value chain stage
Raw MaterialsManufacturingEnd of Life
Metric assessment
Relevance:High
Feasibility:Low
Related Actions
Reduce water use and wastage, particularly in water-stressed areas
Reduce operational waste through improved material efficiency and reuse
Reduce upstream water use by engaging with suppliers and encouraging the adoption of more water-efficient processes, particularly in water-stressed areas
Reduce waste to landfill by introducing a waste hierarchy into management systems
Reduce water and soil pollution risk from APIs, especially antibiotics, harmful chemicals and other relevant substances from manufacturing sites
Reduce APIs (including antibiotics) in the environment by investing in and supporting the development of technologies that enhance the removal of pharmaceutical residues from wastewater